IN2014DN06213A - - Google Patents
Info
- Publication number
- IN2014DN06213A IN2014DN06213A IN6213DEN2014A IN2014DN06213A IN 2014DN06213 A IN2014DN06213 A IN 2014DN06213A IN 6213DEN2014 A IN6213DEN2014 A IN 6213DEN2014A IN 2014DN06213 A IN2014DN06213 A IN 2014DN06213A
- Authority
- IN
- India
- Prior art keywords
- linezolid
- isomer
- relative
- hydroxide
- provides
- Prior art date
Links
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 abstract 9
- 229960003907 linezolid Drugs 0.000 abstract 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 3
- 239000013078 crystal Substances 0.000 abstract 1
- -1 linezolid compound Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention relates to a substantially pure linezolid hydroxide having R isomer content more than about 99.9% relative to its S isomer. Further aspect of invention provides the ambient moisture condition which is critical for enantiomeric pure linezolid hydroxide. The obtained substantially enantiomerically pure linezolid hydroxide compound of formula II can be subsequently converted into the linezolid compound of formula I having S isomer content more than 99.9% relative to R isomer. Further the invention provides an improved process for preparation of enantiomeric pure linezolid Form I wherein linezolid Form I having the purity more than 99.9% relative to any other known polymorphic form of linezolid. The obtained enantiomeric pure linezolid Form I can be subsequently converted into the other known polymorphic forms linezolid. The invention also provides stable and substantially solvent free crystal of Form I of linezolid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN6213DEN2014 IN2014DN06213A (en) | 2012-01-24 | 2013-01-22 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2254DE2012 | 2012-07-19 | ||
| IN267DE2012 IN2012DE00267A (en) | 2012-01-31 | 2013-01-22 | |
| IN200DE2012 IN2012DE00200A (en) | 2012-01-24 | 2013-01-22 | |
| PCT/IB2013/050537 WO2013111048A1 (en) | 2012-01-24 | 2013-01-22 | Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent |
| IN6213DEN2014 IN2014DN06213A (en) | 2012-01-24 | 2013-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06213A true IN2014DN06213A (en) | 2015-10-23 |
Family
ID=47884428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6213DEN2014 IN2014DN06213A (en) | 2012-01-24 | 2013-01-22 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20150025236A1 (en) |
| EP (1) | EP2852580A1 (en) |
| IN (1) | IN2014DN06213A (en) |
| WO (1) | WO2013111048A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108117527A (en) * | 2018-01-12 | 2018-06-05 | 上海龙翔生物医药开发有限公司 | A kind of I preparation method of linezolid form suitable for industrialized production |
| CN119119019B (en) * | 2024-09-11 | 2025-11-11 | 遵义医科大学 | Heterocyclic sulfonamide/sulfonate derivative and preparation method and application thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| MY115155A (en) * | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| DK1114819T3 (en) | 1996-04-11 | 2008-04-14 | Pharmacia & Upjohn Co Llc | Process for the preparation of oxazolidinones |
| EP1772453A1 (en) | 1997-11-07 | 2007-04-11 | Pharmacia & Upjohn Company LLC | Process to produce Oxazolidinones |
| AR027261A1 (en) | 2000-02-02 | 2003-03-19 | Upjohn Co | LINEZOLID CRYSTAL FORM II |
| US6444813B2 (en) | 2000-02-02 | 2002-09-03 | Pharmacia & Upjohn Company | Linezolid-crystal form II |
| PT1673370E (en) | 2003-10-16 | 2009-11-05 | Symed Labs Ltd | Crystalline form of linezolid |
| WO2006091731A2 (en) | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| US20090093631A1 (en) | 2007-09-06 | 2009-04-09 | Ben-Zion Dolitzky | Processes for the preparation of a linezolid intermediate, linezolid hydroxide |
| WO2009063505A2 (en) * | 2007-10-08 | 2009-05-22 | Usv Limited | Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide |
| WO2010084514A2 (en) | 2009-01-02 | 2010-07-29 | Neuland Laboratories Ltd. | A process for the preparation of (5s)-(n)-[[3-[3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide |
| WO2011050826A1 (en) * | 2009-10-28 | 2011-05-05 | Synthon B.V. | Process for making crystalline form a of linezolid |
| WO2011077310A1 (en) | 2009-12-26 | 2011-06-30 | Alembic Limited | Process for the preparation of linezolid |
| WO2011114210A2 (en) | 2010-03-15 | 2011-09-22 | Jubilant Life Sciences Limited | Processes for the preparation of linezolid |
| WO2014013498A1 (en) * | 2012-07-17 | 2014-01-23 | Symed Labs Limited | Amorphous coprecipitates of linezolid |
-
2013
- 2013-01-22 IN IN6213DEN2014 patent/IN2014DN06213A/en unknown
- 2013-01-22 US US14/374,213 patent/US20150025236A1/en not_active Abandoned
- 2013-01-22 EP EP13709542.8A patent/EP2852580A1/en not_active Withdrawn
- 2013-01-22 WO PCT/IB2013/050537 patent/WO2013111048A1/en not_active Ceased
-
2016
- 2016-11-18 US US15/356,374 patent/US20170066728A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170066728A1 (en) | 2017-03-09 |
| EP2852580A1 (en) | 2015-04-01 |
| US20150025236A1 (en) | 2015-01-22 |
| WO2013111048A1 (en) | 2013-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013501199A1 (en) | Photochromic compounds and compositions | |
| NZ739757A (en) | Processes for preparing jak inhibitors and related intermediate compounds | |
| NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
| IN2014MN01521A (en) | ||
| MX350211B (en) | Process for preparing n-(4-cyclohexyl-3-trifluoromethyl-benzyloxy )-acetimidic acid ethyl ester. | |
| MX375073B (en) | 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal | |
| MX2020009790A (en) | Process for making quinolone compounds. | |
| IN2014DN10617A (en) | ||
| IN2014MN00976A (en) | ||
| BR112014004523A2 (en) | flavoring compound and composition | |
| WO2013190455A3 (en) | Process for the preparation of lurasidone hydrochloride | |
| WO2018125983A8 (en) | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors | |
| IN2013MU03442A (en) | ||
| MX342273B (en) | Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-yl methyl-indol-1-yl)-acetic acid esters. | |
| EA201201293A1 (en) | HYDRATE OF HYDROBROMIDE AGOMELATIN AND ITS GETTING | |
| IN2014DN06213A (en) | ||
| WO2014087208A3 (en) | A process of preparing alcaftadine | |
| BR112015015880A2 (en) | A process for producing the compound, compound of formula, pharmaceutical preparation and substantially innovative compounds, compositions, methods and uses | |
| EP4282973A3 (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| JO2812B1 (en) | New Process for obtaining the crystalline form V of agomelatine | |
| MX2013004193A (en) | Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives. | |
| NZ711329A (en) | A process for preparation of (2s, 5r)- sulfuric acid mono-{ [(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester | |
| WO2013117869A3 (en) | Method for enzymatically synthesizing (7s)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid or the esters thereof, and use in the synthesis of ivabradine and the salts thereof | |
| IN2012DE00200A (en) | ||
| NZ606574A (en) | Novel synthesis for thiazolidinedione compounds |